Related Experiment Video
Updated: Mar 21, 2026

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.6K
Protein Complex Production from the Drug Discovery Standpoint
1Crelux GmbH, Am Klopferspitz 19a, D82152, Martinsried, Germany. moarefi@crelux.com.
Advances in Experimental Medicine and Biology
|May 12, 2016
Summary
Discovering new drugs requires effective in vitro assays. Using protein complexes as targets, rather than single proteins, can improve drug discovery efficiency and reduce late-stage failures.
Area of Science:
- Biochemistry
- Pharmacology
- Drug Discovery
Background:
- * Small molecule drug discovery relies on in vitro assays for optimizing drug potency and selectivity.
- * Disease-relevant drug targets often function as protein complexes, not single proteins.
- * Protein cofactors are crucial for the function and regulation of many drug targets.
Purpose of the Study:
- * To review the trend of using protein complexes in drug discovery.
- * To highlight examples of rational drug design using protein complexes.
- * To demonstrate how this approach can reduce late-stage drug development attrition.
Main Methods:
- * Literature review of recent studies.
- * Analysis of case examples in rational drug discovery.
- * Focus on biologically relevant protein complexes as therapeutic targets.
Main Results:
- * Increasing use of protein complexes in drug discovery assays.
- * Examples show improved understanding of target function within complexes.
- * Potential for enhanced drug efficacy and reduced toxicity.
Conclusions:
- * Targeting protein complexes represents a significant advancement in drug discovery.
- * This strategy offers a more biologically relevant approach to identifying drug candidates.
- * Utilizing protein complexes can mitigate risks associated with efficacy and toxicity in later development phases.
Related Concept Videos
Drug Discovery: Overview
12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
Protein Complex Assembly
17.1K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
17.1K
Protein Complex Assembly
2.7K
2.7K
Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Protein-Drug Binding: Mechanism and Kinetics
2.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
Protein-Drug Binding: Determination Methods
767
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
767

